Behçet's Uveitis
- PMID: 20404988
- PMCID: PMC2855662
- DOI: 10.4103/0974-9233.58425
Behçet's Uveitis
Abstract
Behçet's disease is a multisystem inflammatory disorder that is most common in countries along the ancient "Silk Road". The eye is the most commonly involved vital organ in Behçet's patients and the typical form of involvement is a relapsing remitting panuveitis and retinal vasculitis. Uveitis is the initial manifestation of the disease in 10-15% of the patients. Anterior uveitis is always nongranulomatous. Diffuse vitritis, retinal infiltrates, sheathing of predominantly retinal veins, and occlusive vasculitis are the typical signs of posterior segment inflammation. Spontaneous resolution of acute inflammatory signs is a diagnostic feature. Fundus fluorescein angiography is the gold standard in monitoring inflammatory activity. Laser flare photometry is a useful noninvasive tool since flare readings correlate with fluorescein angiographic leakage. The most common complications are cataract, maculopathy, and optic atrophy. Male patients have a more severe disease course and worse visual prognosis. Immunomodulatory therapy is indicated in all patients with posterior segment involvement. Corticosteroids combined with azathioprine and/or cyclosporine is used initially. Biologic agents, including interferon alfa and infliximab, are used in resistant cases. Visual prognosis has improved in recent years with an earlier and more aggressive use of immunomodulatory therapy and the use of biologic agents in resistant cases.
Keywords: Behçet's Disease; Immunomodulatory Treatment; Retinal Vasculitis; Uveitis.
Conflict of interest statement
Figures






Similar articles
-
[Ocular manifestations in Behçet's disease].Rev Med Interne. 2018 Sep;39(9):738-745. doi: 10.1016/j.revmed.2018.02.022. Epub 2018 Apr 4. Rev Med Interne. 2018. PMID: 29625716 Review. French.
-
Clinical features of chinese patients with Behçet's disease.Ophthalmology. 2008 Feb;115(2):312-318.e4. doi: 10.1016/j.ophtha.2007.04.056. Epub 2007 Aug 10. Ophthalmology. 2008. PMID: 17692378
-
[Ocular manifestations in Behçet's disease].Rev Med Interne. 2014 Feb;35(2):97-102. doi: 10.1016/j.revmed.2013.10.011. Epub 2013 Nov 27. Rev Med Interne. 2014. PMID: 24290834 Review. French.
-
[Eye and Behçet's disease].J Fr Ophtalmol. 2019 Jun;42(6):626-641. doi: 10.1016/j.jfo.2018.09.027. Epub 2019 Jun 1. J Fr Ophtalmol. 2019. PMID: 31164292 Review. French.
-
Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308. Turk J Ophthalmol. 2020. PMID: 32631005 Free PMC article. Review.
Cited by
-
Pattern of Uveitis Associated with Behçet's Disease in an Egyptian Cohort.Clin Ophthalmol. 2020 Nov 20;14:4005-4014. doi: 10.2147/OPTH.S287298. eCollection 2020. Clin Ophthalmol. 2020. PMID: 33262566 Free PMC article.
-
Systemic Immunomodulatory Therapy in Uveitis Related to Behçet's Disease: A 10-year Profile.Clin Ophthalmol. 2025 Jul 5;19:2133-2141. doi: 10.2147/OPTH.S524282. eCollection 2025. Clin Ophthalmol. 2025. PMID: 40635976 Free PMC article.
-
Ocular Behçet Disease-Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset.Biomedicines. 2023 Feb 19;11(2):624. doi: 10.3390/biomedicines11020624. Biomedicines. 2023. PMID: 36831160 Free PMC article.
-
The Effect of Vision-Related Quality of Life on Depression and Anxiety in Patients with Behçet Uveitis.Turk J Ophthalmol. 2021 Dec 28;51(6):358-364. doi: 10.4274/tjo.galenos.2020.06791. Turk J Ophthalmol. 2021. PMID: 34963263 Free PMC article.
-
Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6. J Neuroinflammation. 2024. PMID: 38778397 Free PMC article. Review.
References
-
- Behçet H. über rezidivierende aphthöse durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152–7.
-
- Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297–350. - PubMed
-
- Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: Historical and geographical perspectives. Tissue Antigens. 1999;54:213–20. - PubMed
-
- Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–6. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources